Stryker LFIT V40 Femoral Head

The Stryker LFIT V40 femoral head docket, with 47 actions coordinated in the District of Massachusetts, is a moderately sized, mature hip-implant litigation distinct from Stryker's earlier Rejuvenate and ABG II docket. Claims here allege that a specific femoral head component, used with multiple Stryker hip stems rather than a single hip system, can corrode or fret at its taper connection, causing elevated metal-ion levels, tissue damage, and revision surgery.

Because the LFIT V40 head was used across multiple stem systems, a claim's specific stem-and-head combination is a meaningful underwriting variable, distinct from a single-product hip docket where every claim shares an identical implant configuration. Funders should expect claim files to include implant records identifying the specific components used, metal-ion testing, and revision-surgery documentation, consistent with what nearly a decade of litigation in this docket has typically generated.

Medical liens are a standard consideration given the cost of hip-revision surgery. With a moderate remaining claim count, this docket supports either individual claim underwriting or a modest portfolio structure for a firm holding multiple LFIT V40 matters, though the component-combination variable means claim-by-claim diligence remains important even within a portfolio. Absent a docket-wide global settlement announced for this specific component line, funding structures should be built around this docket's own bellwether and case-resolution record rather than assumptions carried over from Stryker's separate Rejuvenate/ABG II settlement history, since the two dockets involve different components, different defect mechanisms, and different resolution timelines even though they share the same corporate defendant.

Criterica Capital's mass tort finance product applies to claims in this docket. A structural read distinguishing this docket from Stryker's other hip-implant litigation is available through Criterica Intelligence.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.